Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Global Radiodermatitis Treatment Market Analysis
According to Verified Market Research, Global Radiodermatitis Treatment Market was valued at USD 327.63 Million in 2018 and is projected to reach USD 441.88 Million by 2026, growing at a CAGR of 3.83 % from 2019 to 2026.
What is Radiodermatitis Treatment?
Radiation dermatitis is a reaction caused due to radiotherapy cancer treatment which results due to tissue damage, DNA damage, and inflamed skin. It can be treated by topical, oral medication or dressing. It is also known as x-ray dermatitis, radiation skin damage or a radiation burn.
Global Radiodermatitis Treatment Market Outlook
Increasing practices of radiation therapy owing to improving quality assurance and consistency in treatment protocols across multiple centres has resulted in the increased prevalence of radiodermatitis. Analysis says that more than half of patients treated with radiotherapy suffer from radiodermatitis at some point during treatment. Radiation therapy is recognized as an essential element and treatment for cancer across the world. Based on estimates, it has been found more than 14 million new cases of cancer are diagnosed globally each year, radiation therapy (RT) has the potential to improve the rates of cure of 3.5 million people and provide soothing relief and has the potential to cure more population. Radiation dermatitis is commonly treated with low-level light therapy. However, risk factors and high cost associated with treatment restrains the market growth. Future therapies may become available for radiation dermatitis owing to increasing spending on research, for which global players are undergoing rapid consolidation. Therapies will need to be thoroughly tested in well-designed trials properly identify best practices and patent registration.
Global Radiodermatitis Treatment Market Competitive Landscape
The "Global Radiodermatitis Treatment Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such as 3M, Acelity LP Inc., ConvaTec Group Plc, Mölnlycke Health Care AB, Smith & Nephew Plc, Derma Sciences, Stratpharma, BMG Pharma and Laboratorios LETI and Alliqua BioMedical. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis.
Customization of the Report
• In case of any queries or customization requirements please connect with our sales team, who will ensure that your requirements are met.